Compare GLW & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLW | ABT |
|---|---|---|
| Founded | 1851 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.2B | 152.9B |
| IPO Year | 2008 | 2006 |
| Metric | GLW | ABT |
|---|---|---|
| Price | $156.12 | $100.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 20 |
| Target Price | ★ $146.91 | $130.90 |
| AVG Volume (30 Days) | ★ 12.9M | 8.6M |
| Earning Date | 04-28-2026 | 04-16-2026 |
| Dividend Yield | 0.74% | ★ 2.76% |
| EPS Growth | ★ 215.52 | N/A |
| EPS | 0.43 | ★ 0.61 |
| Revenue | $15,629,000,000.00 | ★ $44,328,000,000.00 |
| Revenue This Year | $20.74 | $10.75 |
| Revenue Next Year | $12.80 | $8.10 |
| P/E Ratio | $358.15 | ★ $164.90 |
| Revenue Growth | ★ 19.14 | 5.67 |
| 52 Week Low | $54.89 | $81.97 |
| 52 Week High | $271.78 | $137.49 |
| Indicator | GLW | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 38.48 | 64.90 |
| Support Level | $153.33 | $100.88 |
| Resistance Level | $156.17 | $103.84 |
| Average True Range (ATR) | 10.15 | 2.32 |
| MACD | -4.87 | 0.72 |
| Stochastic Oscillator | 13.49 | 91.50 |
Corning is a provider of glass, ceramics, and optical fiber across six distinct end markets. Corning's largest segments by revenue are display glass for TVs and optical fiber for telecom networks and data centers. It also provides cover glass for smartphones as well as filters and substrates and glass for cars, produces pharmaceutical glass, and produces polysilicon for solar panels. Corning is a US producer and is vertically integrated across its products and markets.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.